No Detail Found!

Seroprevalence of Human T-cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.

Author(s)
Saifullah Khan Niazi Department of Screening, Armed Forces Institute of Transfusion (AFIT), Rawalpindi, Pakistan
Farhat Abbas Bhatti Department of Blood Transfusion, Armed Forces Institute of Transfusion (AFIT), Rawalpindi, Pakistan
Nuzhat Salamat Department of Blood Transfusion, Armed Forces Institute of Transfusion (AFIT), Rawalpindi, Pakistan
Abstract
Objective: To determine the seroprevalence of Human T-cell Lymphotropic Virus-1/2 (HTLV-1/2) in blood donors in Northern Pakistan. Study Design: Descriptive study. Place and Duration of Study: Armed Forces Institute of Transfusion, Rawalpindi, from July to August 2013. Methodology: A total of 2100 blood donors were screened for anti-HTLV-1/2 antibodies during the study period, in a pool of six, on a highly sensitive, Chemiluminiscent Microparticle Immunoassay (CMIA) based system. The screening testreactive donors were recalled, counseled and interviewed, and a fresh sample was obtained for confirmatory testing. Confirmation was performed using additional immunoassays including Line Immunoassay (LIA); with additional testing for HTLV-1 pvDNA PCR. Frequency and percentages were determined. Results: Four donors (0.19%) were repeatedly screening test-reactive and were subsequently confirmed to be HTLV-1 infected by line immunoassay and HTLV-1 pvDNA PCR. All four donors were male with mean age of 27 ±6.27 years. Two (50%) of the positive donors gave history of Multiple Sexual Partners (MSP). Conclusion: HTLV-1 seroprevalence in Northern Pakistan blood donors was determined to be 0.19%. Large scale studies, including the cost effectiveness of screening blood donations for anti-HTLV-1/2 in Pakistan, are recommended.
Publication Details
Page(s) 874-877
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 25, Issue: 12, Year: 2015

Request the full text from PASTIC

References
BlattnerWA,KalynaramanVS,Robert-GuroffM,ListerTA,GaltonDA,SarinPS, 1982.The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/ lymphoma,Int J Cancer 30 257 -64
TreviñoA,VicarioJL,LopezM,ParraP,BenitoR,Ortiz de Lejarazu R,J Neurol, 2013.Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1, 260 2551 -5
ProiettiFA,Carneiro-ProiettiAB,Catalan-SoaresBC,MurphyEL, 2005.Global epidemiology of HTLV-I infection and associated diseases,Oncogene 24 6058 -68
CalattiniS,ChevalierSA,DuprezR,BassotS,FromentA,MahieuxR, 2005.Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa,Retrovirology 2 30 -
TakatsukiK,MatsuokaM, 1996.Yamaguchi K. Adult T-cell leukemia in Japan,J Acquir Immune Defic Syndr Hum Retrovirol 13 S15 -S19
AlvaIE,OrellanaER,BlasMM,Bernabe-OrtizA,CotrinaA,ChiappeM, 2012.HTLV-1 and -2 infections among 10 indigenous groups in the Peruvian Amazon,Am J Trop Med Hyg 87 954 -6
DelaporteE,PeetersM,DurandJP,DupontA,SchrijversD,BedjabagaL, 1989.Seroepidemiological survey of HTLV-1 infection among randomized populations of western central African countries,J Acquir Immune Defic Syndr 2 410 -3
AbbaszadeganMR,GholaminM,TabatabaeeA,FaridR,HoushmandM,AbbaszadeganM, 2003.Prevalence of human T-lymphotropic virus type-1 among blood donors from Mashhad, Iran,J Clin Microbiol 41 2593 -5
MannsA,WilksRJ,MurphyEL,HaynesG,FigueroaJP,BarnettM, 1992.A progressive study of transmission by transfusion of HTLV-1 and risk factors associated with seroconversion,Int J Cancer 51 886 -91
CouroucéAM,PillonelJ,LemaireJM, 1998.HTLV testing in blood transfusion,Vox Sang 74 165 -9
AnderssonS,GessainA,Taylor G, 2001.Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus (HTLV) types I and II,Virus Res 78 101 -6
DowBC,MunroH,FergusonK,BuchananI,JarvisL,JordanT, 2001.HTLV antibody screening using mini-pools,Transfus Med 11 419 -22
Ul-HassanZ,Al-BahraniAT,PanhotraBR, 2004.Prevalence of human T-lymphotropic virus type-I and type-II antibody among blood donors in Eastern Saudi Arabia,Saudi Med J 25 1419 -22
MaY,ZhengS,WangN,DuanY,SunX,JinJ, 2013.Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China,PLoS One 8 e66795 -
ChangYB,KaidarovaZ,HindesD,BravoM,KielyN,KamelH, 2014.Seroprevalence and demographic determinants of human T-lymphotropic virus type-1 and 2 infections among first-time blood donors-United States,,J Infect Dis 209 523 -31
TynellE,AnderssonS,LithanderE,ArnebornM,BlombergJ,HanssonHB, 1998.Screening for human T-cell leukaemia/ lymphoma virus among blood donors in Sweden: cost effectiveness analysis,BMJ 316 1417 -22
DavisonKL,DowB,BarbaraJA,HewittPE,EglinR., 2009.The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV,Transfus Med 19 24 -34
GastaldelloR,HallWW,GallegoS., 2004.Seroepidemiology of HTLV-I/II in Argentina: an overview,J Acquir Immune Defic Syndr 35 301 -8
RouetF,RabierR,FoucherC,ChancerelB,AgisF,StrobelM., 1999.Geographical clustering of human T-cell lymphotropic virus type-I in Guadeloupe, an endemic Caribbean area,Int J Cancer 81 330 -4
PintoMT,RodriguesES,MaltaTM,AzevedoR,TakayanaguiOM,ValenteVB, 2012.HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up,Rev Inst Med Trop Sao Paulo 54 123 -9
RouetF,FoucherC,RabierM,GawronskiI,TaverneD,ChancerelB, 1999.Human T-lymphotropic virus type-I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics,Transfusion 39 639 -44
GoutO,BaulacM,GessainA,SemahF,SaalF,PérièsJ, 1990.Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation,N Engl J Med 322 383 -8
SatakeM,YamaguchiK,TadokoroK., 2012.Current prevalence of HTLV-1 in Japan as determined by screening of blood donors,J Med Virol 84 327 -5
0

Citations

0

Downloads

67

Views